Senator Maggie Hassan is investigating GSK's discontinuation of Flovent HFA, citing increased hospitalizations, higher drug ...

GSK (GSK) faces an investigation from U.S. Senator Maggie Hassan over its decision to discontinue Flovent HFA asthma inhaler ...

Hassan cited a Johns Hopkins analysis which found that GSK's move saved the company $367 million in 2024 Medicaid rebates, ...

Digital inhalers may help predict occurrence of acute exacerbations of COPD for patients in an ambulatory setting.

U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...

Asthma and COPD have a huge impact upon the individual and upon the NHS in general. There are over 5.2 million people with asthma in the UK.

Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

The Hailie Smartinhaler device has also been cleared for use with inhalers from other manufacturers, including GSK, Boehringer Ingelheim, and Teva, and Adherium also sells the device directly to ...

Session ID: 2025-06-29:ea1efbad217b8a6d6ba30341 Player Element ID: V0a7e7ff7_116c_42d2_98ed_a6304e42a4fb_6285641102001 ...

Mar. 12, 2025 — A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, researchers have found.